Katie Hill, MPH

she/her/hers

DownloadHi-Res Photo

Contact Info

k.hill@yale.edu

Education

MPH
Milken Institute School of Public Health at George Washington University, Epidemiology (2022)

BA
University of Virginia, Biology and Interdisciplinary Studies (2018)

About

Biography

Katherine (Katie) Hill is a PhD candidate in Epidemiology of Microbial Diseases working under the mentorship of Dr. Robert Heimer. She is also a Public Health Workforce Development Fellow with the Office of Public Health Practice. Her research interests include substance use, harm reduction, xylazine, kratom, sexual health and behavior, and improving the health of incarcerated individuals.

Last Updated on October 06, 2024.

Education & Training

MPH: Milken Institute School of Public Health at George Washington University, Epidemiology (2022)

BA: University of Virginia, Biology and Interdisciplinary Studies (2018)

Research

Overview

Medical Research Interests

Community-Based Participatory Research; Controlled Substances; Public Health Systems Research; Soft Tissue Injuries; Substance-Related Disorders; Veterinary Drugs

Public Health Interests

Community Health; Health Equity, Disparities, Social Determinants and Justice; Implementation Science; Mental Health; Sexually-Transmitted Infections; Stigma and Discrimination; Substance Use, Addiction

ORCID
0000-0002-6515-8701

Research at a Glance

Yale Co-Authors

Frequent collaborators of Katie Hill's published research.

Robert Heimer, PhD
View Full Profile
View 3 Common Publications
Jenna L. Butner, MD, MPH, FASAM, AAHIVS
View Full Profile
View 2 Common Publications
Benjamin Howell, MD, MPH, MHS
View Full Profile
View Common Publication
Emma Biegacki, MPH
View Full Profile
View Common Publication
Lauretta Grau, PhD
View Full Profile
View Common Publication
Mahalia S. Desruisseaux, MD
View Full Profile
View Common Publication

Publications

2026

An Approach to Building a Strong Public Health Workforce: The Connecticut Public Health Fellowship Program.
Nappi S, Allen N, Hill K, Aviles E, Meise-Munns E, Petros M, Asada Y, Jarpe-Ratner E, Lane J, Pérez-Escamilla R. An Approach to Building a Strong Public Health Workforce: The Connecticut Public Health Fellowship Program. J Public Health Manag Pract 2026, 32: 34-43. PMID: 41260590, DOI: 10.1097/PHH.0000000000002275.
Peer-Reviewed Original Research
Diversification of Kratom in US Markets: Results from an Online Survey and Chemical Assay of Products.
Hill K, Henderson A, Sharma A, Kanumuri SRR, Mukhopadhyay S, Veltri C, Smith KE, McCurdy CR, Grundmann O. Diversification of Kratom in US Markets: Results from an Online Survey and Chemical Assay of Products. Subst Use Misuse 2026, 61: 237-246. PMID: 40853511, DOI: 10.1080/10826084.2025.2551707.
Peer-Reviewed Original Research

2025

Clinically characterizing adults who use kava or kratom: Substance use disorder assessment challenges for increasingly popular botanical products.
Hill K, Boyer EW, Smith KE. Clinically characterizing adults who use kava or kratom: Substance use disorder assessment challenges for increasingly popular botanical products. Drug Alcohol Depend Rep 2025, 17: 100394. PMID: 41322679, DOI: 10.1016/j.dadr.2025.100394.
Peer-Reviewed Original Research
In Support of a Public Health Approach to Drug Policy: Position Statement of AMERSA, Inc.
Hill K, Rife-Pennington T, Zagorski C, Dunham K, Sue K, Davis C, Incze M. In Support of a Public Health Approach to Drug Policy: Position Statement of AMERSA, Inc. Substance Use & Addiction Journal 2025, 29767342251381162. PMID: 41199684, DOI: 10.1177/29767342251381162.
Peer-Reviewed Original Research
Concepts
Tianeptine Products: Public Health Threat or Niche Substance use?
Smith KE, Hill K, Bergeria CL, Strickland JC. Tianeptine Products: Public Health Threat or Niche Substance use? J Psychoactive Drugs 2025, 1-11. PMID: 41084181, DOI: 10.1080/02791072.2025.2570939.
Peer-Reviewed Original Research
“Everybody’s Liking It”—Intentional Use of Xylazine in Fentanyl Among People Who Use Drugs
Hill K, Heimer R, Sue K. “Everybody’s Liking It”—Intentional Use of Xylazine in Fentanyl Among People Who Use Drugs. Substance Use & Misuse 2025, ahead-of-print: 1-8. PMID: 40847818, DOI: 10.1080/10826084.2025.2549499.
Peer-Reviewed Original Research
Concepts
Community-Originated Research to Identify Access Gaps in Over-the-Counter Naloxone Availability in Connecticut Pharmacies.
Hill K, Canning P, Canning Z, Breen C, Evans L, Jenkins M, Nickel M, Plourd K, Heimer R. Community-Originated Research to Identify Access Gaps in Over-the-Counter Naloxone Availability in Connecticut Pharmacies. Harm Reduct J 2025, 22: 119. PMID: 40660265, DOI: 10.1186/s12954-025-01268-y.
Peer-Reviewed Original Research
De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing.
Hill K, Boyer EW, Grundmann O, Smith KE. De facto opioids: Characterization of novel 7-hydroxymitragynine and mitragynine pseudoindoxyl product marketing. Drug Alcohol Depend 2025, 272: 112701. PMID: 40373645, DOI: 10.1016/j.drugalcdep.2025.112701.
Peer-Reviewed Original Research
A composite vignette: xylazine, infectious complications and the importance of community-based drug checking services
John L, Flint N, Piccolo F, Hill K, Anderson M, Townsend B, Fletcher M, Altomare-Jarczyk C, Silvia K, Green T, Thamattoor D, Bessette J, Thakarar K. A composite vignette: xylazine, infectious complications and the importance of community-based drug checking services. Therapeutic Advances In Infectious Disease 2025, 12: 20499361251365090. PMID: 40822666, PMCID: PMC12357011, DOI: 10.1177/20499361251365090.
Peer-Reviewed Original Research
Concepts
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use.
Hill K, Rogers JM, Grundmann O, Epstein DH, Smith KE. At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom use. Am J Drug Alcohol Abuse 2025, 51: 191-203. PMID: 39883932, DOI: 10.1080/00952990.2024.2414319.
Peer-Reviewed Original Research

See All Publications

News

See All News

Get In Touch

Contacts

k.hill@yale.edu

Contact Info

Education

Biography

Education & Training

Overview

Medical Research Interests

Public Health Interests

ORCID

Research at a Glance

Yale Co-Authors

Robert Heimer, PhD

Jenna L. Butner, MD, MPH, FASAM, AAHIVS

Benjamin Howell, MD, MPH, MHS

Emma Biegacki, MPH

Lauretta Grau, PhD

Mahalia S. Desruisseaux, MD

Publications

2026

2025

News

CT’s health commissioners should support overdose prevention centers

Opinion: The need for overdose prevention centers in Connecticut

Cause of Death After Prison Release Differs From General Population

For CT’s incarcerated, health care becomes an opportunity for punishment

Contacts